flâneur

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging | ScienceDaily

sciencedaily.com · 947 words · saved by 1 readers

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly.

The growing popularity of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus has largely been driven by their ability to help people lose weight, improve blood sugar control, and reduce the risk of cardiovascular disease. Now, researchers have uncovered another possible benefit. A new clinical trial suggests that semaglutide, the active ingredient in those medications, may also help slow some of the biological processes associated with aging. Published in Nature Communications, the study provides the first randomized, placebo-controlled evidence in humans that semaglutide may slow the…

saved by

related reading